| Page 1282 | Kisaco Research
 

Robert Brooks

CEO
Alphageneron

Robert Brooks

CEO
Alphageneron

Robert Brooks

CEO
Alphageneron
 

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics
 

Monique Dao

VP, Translational Medicine, Immunology
bit.bio

Monique Dao

VP, Translational Medicine, Immunology
bit.bio

Monique Dao

VP, Translational Medicine, Immunology
bit.bio
 

Mariska ter Haak

Director, Analytical Development
IN8bio

Mariska ter Haak

Director, Analytical Development
IN8bio

Mariska ter Haak

Director, Analytical Development
IN8bio
 

Marc Davies

VP, CAR Engineering
Leucid Bio

Marc Davies

VP, CAR Engineering
Leucid Bio

Marc Davies

VP, CAR Engineering
Leucid Bio
 

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences
 

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics
 

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell
 

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics
 

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie